IPO Boutique

Quintiles Transnational IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Quintiles Transnational, and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Quintiles TransnationalQ - $36.00-$40.00 $40.00 $43.7623.7 million5/9/2013
Morgan Stanley, Barclays, J.P. Morgan
Co-Manager(s):
Citigroup, Goldman Sachs & Co., Wells Fargo Securities, BofA Merrill Lynch, Deutsche Bank Securities, Baird, William Blair, Jefferies, Guggenheim Securities, Piper Jaffray, Raymond James, RBC Capital Markets, UBS Investment Bank
Health Care
Filing(s):




Quintiles Transnational Quote & Chart - Click for current quote - Q

About Quintiles Transnational (adapted from Quintiles Transnational prospectus):
They are the largest provider of clinical trial services to pharmaceutical companies.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "Q" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved